Prostate Cancer News on BioPortfolio

Arvinas closes $55mm Series C round

Arvinas Inc. developing cancer therapeutics based on protein degradation raised $55mm through its Series C round from new investors Nextech Invest lead Deerfield Management Hillhouse Capital and Sirona Capital as well as returning backers Canaan Partners 5...

Genetic Risk Scores GRSs Ready for Inclusion in the Medical Record

Dr. Eric Topol has commented on Twitter about the introduction of genetic risk scores GRSs into patients' EHRs. In his tweets he refers to articles in medical journals on this topic one of which is the following Polygenic hazard score to guide screening fo...

Pages